Sanghamitra Saha

Key Takeaways Healthcare earnings are poised to accelerate, improving the sector's growth outlook. M&A activity and strong FDA approvals are supporting pharma stocks.

Key Takeaways Senior loans and floating-rate ETFs can offer protection as interest rates rise. Short-duration bond ETFs can limit interest-rate risk while generating income.

Key Takeaways CANC hit a 52-week high after surging more than 3% on Aug. 19. Moderna's melanoma trial success boosted sentiment across oncology stocks.

Key Takeaways Bitcoin's Treasury-driven rally and short squeeze lifted major Bitcoin ETFs.

Key Takeaways SK Hynix's $28.7 billion buyback could provide meaningful downside support for shares.

Key Takeaways A strong El Nino could disrupt agriculture, energy and global supply chains. DBA, CANE and MOO offer ways to target potential agricultural gains.

Key Takeaways Moderna-driven gains propelled leveraged biotech ETFs to triple-digit returns. Crypto's rebound boosted leveraged XRP, Ether and Bitcoin-linked ETFs.

Key Takeaways Dollar weakness could benefit inverse-dollar, gold and commodity ETFs. De-dollarization trends may create opportunities in emerging-market ETFs.

Key Takeaways Bitcoin surged more than 20% in days, fueled by policy optimism and short covering.

Key Takeaways NVIDIA's AI demand and Blackwell momentum support strong Q2 growth. Attractive valuation could strengthen NVIDIA's investment case ahead of earnings.